List of Excipients in API metyrapone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing metyrapone
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
HRA Pharma Rare Diseases | METOPIRONE | metyrapone | 76336-455 | 4-ACETYLANISOLE | |
HRA Pharma Rare Diseases | METOPIRONE | metyrapone | 76336-455 | ETHYL VANILLIN | |
HRA Pharma Rare Diseases | METOPIRONE | metyrapone | 76336-455 | ETHYLPARABEN SODIUM | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for metyrapone
Excipient focus: 4-ACETYLANISOLE
metyrapone drug variants containing 4-ACETYLANISOLE
Company | Ingredient | NDC |
---|---|---|
HRA Pharma Rare Diseases | metyrapone | 76336-455 |
>Company | >Ingredient | >NDC |
metyrapone drug variants not containing 4-ACETYLANISOLE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ETHYL VANILLIN
metyrapone drug variants containing ETHYL VANILLIN
Company | Ingredient | NDC |
---|---|---|
HRA Pharma Rare Diseases | metyrapone | 76336-455 |
>Company | >Ingredient | >NDC |
metyrapone drug variants not containing ETHYL VANILLIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ETHYLPARABEN SODIUM
metyrapone drug variants containing ETHYLPARABEN SODIUM
Company | Ingredient | NDC |
---|---|---|
HRA Pharma Rare Diseases | metyrapone | 76336-455 |
>Company | >Ingredient | >NDC |
metyrapone drug variants not containing ETHYLPARABEN SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
metyrapone drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
HRA Pharma Rare Diseases | metyrapone | 76336-455 |
>Company | >Ingredient | >NDC |
metyrapone drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
metyrapone drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
HRA Pharma Rare Diseases | metyrapone | 76336-455 |
>Company | >Ingredient | >NDC |
metyrapone drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
metyrapone drug variants containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
HRA Pharma Rare Diseases | metyrapone | 76336-455 |
>Company | >Ingredient | >NDC |
metyrapone drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
metyrapone drug variants containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
HRA Pharma Rare Diseases | metyrapone | 76336-455 |
>Company | >Ingredient | >NDC |
metyrapone drug variants not containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN SODIUM
metyrapone drug variants containing PROPYLPARABEN SODIUM
Company | Ingredient | NDC |
---|---|---|
HRA Pharma Rare Diseases | metyrapone | 76336-455 |
>Company | >Ingredient | >NDC |
metyrapone drug variants not containing PROPYLPARABEN SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
metyrapone drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
HRA Pharma Rare Diseases | metyrapone | 76336-455 |
>Company | >Ingredient | >NDC |
metyrapone drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
metyrapone drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
HRA Pharma Rare Diseases | metyrapone | 76336-455 |
>Company | >Ingredient | >NDC |
metyrapone drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.